ABSTRACT
Heart failure presents a particularly difficult public health challenge. Of the heart failure presentations, acute hypertensive heart failure represents a distinct clinical phenotype and is characterized by sudden-onset systemic hypertension and pulmonary edema. The pathophysiology of acute hypertensive heart failure is primarily driven by an abnormal ventricular-vascular relationship, and the medical management is aimed at improving this relationship.
Subject(s)
Heart Failure , Hypertension , Patient Care Management/methods , Heart Failure/etiology , Heart Failure/physiopathology , Heart Failure/therapy , Humans , Hypertension/complications , Hypertension/physiopathologySubject(s)
Atrioventricular Block/etiology , Myocarditis/complications , Syncope/etiology , Adult , Atrioventricular Block/physiopathology , Atrioventricular Block/therapy , Cardiac Resynchronization Therapy , Electrocardiography , Female , Humans , Myocarditis/diagnosis , Myocarditis/pathology , Myocarditis/physiopathology , Myocardium/pathology , Pacemaker, Artificial , Positron-Emission TomographyABSTRACT
OBJECTIVE: Age at first atherosclerotic event is typically older for women vs. men; monthly iron loss has been postulated to contribute to this advantage. We investigated the relationship between an MRI-based arterial wall biomarker and the serum inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) in perimenopausal women vs. men. METHODS AND RESULTS: Women without evident atherosclerotic disease were prospectively enrolled and observed over 24 months of menopause transition, indicated by hormone levels and reduction in median number of menstrual cycles from 4 [3-6] per year to 0 [0-1] per year (P < 0.01). Higher hsCRP predicted shorter carotid artery wall T2* in women entering the menopause transition (r = -0.3139, P = 0.0014); this relationship weakened after 24 months of perimenopause in women (r = -0.1718, P = 0.0859) and was not significant in a cohort of men matched for age and cardiovascular risk category (r = -0.0310, P = 0.8362). Serum ferritin increased from baseline to 24-month follow-up during women's menopause transition (37 [20-79] to 67 [36-97] ng/mL, P < 0.01), but still remained lower compared to men (111 [45-220] ng/mL, P < 0.01). Circulating ferritin levels correlated with arterial wall T2* values in women at baseline (r = -0.3163, P = 0.0013) but not in women after 24 months (r = -0.0730, P = 0.4684) of menopause transition nor in men (r = 0.0862, P = 0.5644). CONCLUSIONS: An arterial wall iron-based imaging biomarker reflects degree of systemic inflammation in younger women, whereas this relationship is lost as women transition through menopause to become more similar to men. Iron homeostasis and inflammation in the arterial wall microenvironment warrants further investigation as a potential early target for interventions that mitigate atherosclerosis risk.
